Abstract |
Nemo-like kinase (NLK), a proline-directed serine/threonine kinase regulated by phosphorylation, can be localized in the cytosol or in the nucleus. Whether the localization of NLK can affect cell survival or cell apoptosis is yet to be disclosed. In the present study we found that NLK was mainly localized in the nuclei of breast cancer cells, in contrast to a cytosolic localization in non-cancerous breast epithelial cells. The nuclear localization of NLK was mediated through direct interaction with Heat shock protein 27 (HSP27) which further protected cancer cells from apoptosis. The present study provides evidence of a novel mechanism by which HSP27 recognizes NLK in the breast cancer cells and prevents NLK-mediated cell apoptosis.
|
Authors | Gina Shaw-Hallgren, Katarzyna Chmielarska Masoumi, Reihaneh Zarrizi, Ulf Hellman, Per Karlsson, Khalil Helou, Ramin Massoumi |
Journal | PloS one
(PLoS One)
Vol. 9
Issue 5
Pg. e96506
( 2014)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24816797
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- HSP27 Heat-Shock Proteins
- HSPB1 protein, human
- Heat-Shock Proteins
- Intracellular Signaling Peptides and Proteins
- Molecular Chaperones
- Tumor Necrosis Factor-alpha
- Etoposide
- NLK protein, human
- Protein Serine-Threonine Kinases
|
Topics |
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Apoptosis
(drug effects, genetics, physiology)
- Blotting, Western
- Breast Neoplasms
(genetics, metabolism, pathology)
- Cell Line
- Cell Line, Tumor
- Cell Nucleus
(metabolism)
- Cytoplasm
(metabolism)
- Down-Regulation
- Etoposide
(pharmacology)
- Female
- HSP27 Heat-Shock Proteins
(genetics, metabolism)
- Heat-Shock Proteins
- Humans
- Immunohistochemistry
- Intracellular Signaling Peptides and Proteins
(genetics, metabolism)
- MCF-7 Cells
- Microscopy, Confocal
- Molecular Chaperones
- Mutation
- Phosphorylation
- Protein Binding
- Protein Serine-Threonine Kinases
(genetics, metabolism)
- RNA Interference
- Tumor Necrosis Factor-alpha
(pharmacology)
|